Ibex LTD Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Fiona Elizabeth Beck, a Director of IBEX Ltd, received 1,252 shares of common stock on July 31, 2026.
NASDAQ
Mingzhe Zhuang, a Director of IBEX Ltd, received 1,252 shares of common stock on July 31, 2026.
NASDAQ
John William Jones, a Director of IBEX Ltd, received 1,353 shares of common stock on July 31, 2026.
NASDAQ
Bruce Neil Dawson, Chief Sales and CS Officer of IBEX Ltd, reported multiple transactions in common stock on July 31, 2026.
NASDAQ
Taylor C Greenwald, Chief Financial Officer of IBEX Ltd, reported multiple transactions in common stock on July 31, 2026.
NASDAQ
Paul Joseph Inson, Chief People Officer of IBEX Ltd, reported multiple transactions in common stock on July 31, 2026.
NASDAQ
Karen Batungbacal, a Director of IBEX Ltd, received 1,252 shares of common stock on July 31, 2026.
NASDAQ
Patrick Mcginnis, a Director of IBEX Ltd, received 1,252 shares of common stock on July 31, 2026.
NASDAQ
Daniella Ballou-Aares, a Director of IBEX Ltd, received 1,252 shares of common stock on July 31, 2026.
NASDAQ
Julie K Casteel, Chief Sales/Marketing Officer of IBEX Ltd, reported multiple transactions in common stock on July 31, 2026.
NASDAQ
Robert Thomas Dechant, Chief Executive Officer and a Director of IBEX Ltd, reported multiple transactions in common stock on July 31, 2026.
NASDAQ
Christina Alice Trofimuk-O'Connor, Chief Legal Officer of IBEX Ltd, reported multiple transactions in common stock on July 31, 2026.
NASDAQ
David Martin Afdahl, Chief Operating Officer of IBEX Ltd, reported multiple transactions in common stock on July 31, 2026.
NASDAQ
Michael Joseph Darwal, Chief AI & Digital Officer of IBEX Ltd, reported a transaction in 200 shares of common stock on July 20, 2026.
NASDAQ
IBEX Ltd's Chief Financial Officer, Taylor C. Greenwald, reported a transaction involving the withholding of 853 common shares to cover tax liabilities upon the vesting of restricted stock units.
NASDAQ
IBEX Ltd. reports a transaction involving CEO Robert Dechant, where shares were withheld for tax settlement upon vesting of restricted stock units.
NASDAQ
Paul Joseph Inson of IBEX Ltd reports a transaction involving 823 common shares.
NASDAQ
Michael Joseph Darwal, Chief AI & Digital Officer at IBEX Ltd, reported a transaction involving the withholding of shares for tax settlement.
NASDAQ
IBEX Ltd reports a net share settlement by Chief Sales/Marketing Officer Julie K. Casteel to cover tax liabilities upon vesting of restricted stock units.
NASDAQ
IBEX Ltd. reports a net share settlement for Chief Operating Officer David Martin Afdahl, involving shares withheld for tax liabilities upon restricted stock unit vesting.
NASDAQ
IBEX Ltd reports a net share settlement for tax liabilities by Chief Legal Officer Christina Alice Trofimuk-O'Connor.
NASDAQ
Bruce Neil Dawson of IBEX Ltd reported a transaction involving 886 common shares, settled to cover tax liabilities upon the vesting of restricted stock units.
NASDAQ
Julie K. Casteel, Chief Sales/Marketing Officer of IBEX Ltd, sold 3,600 common shares at a weighted average price of $30.6065.
NASDAQ
Director Patrick McGinnis sold 1,030 common shares of IBEX Ltd at a price of $31.69 per share.
NASDAQ
IBEX Limited CFO Taylor Greenwald acquired 3,333 common shares via performance-based units and sold 964 shares to cover tax obligations.
NASDAQ
IBEX Limited CEO Robert Dechant sold 7,800 common shares at a weighted average price of $30.4996 per share.
NASDAQ
Chief Sales and CS Officer Bruce Dawson sold 18,389 common shares of IBEX Ltd across two transactions in May 2026.
NASDAQ
Director Daniella Ballou-Aares reported the sale of 6,500 common shares of IBEX Ltd across multiple transactions.
NASDAQ
IBEX Ltd. Director John William Jones was granted 2,250 restricted stock units, vesting over four years.
NASDAQ
IBEX Ltd director Mingzhe Zhuang received a grant of 2,083 restricted stock units, vesting over four years.